Literature DB >> 15610985

Neurocognitive outcomes in survivors of childhood cancer.

Bartlett D Moore1.   

Abstract

OBJECTIVE: s To review issues associated with neurocognitive outcome in survivors of pediatric cancer. Recommendations are made for future research directions.
METHODS: A large body of literature pertaining to neurocognitive outcome in cancer survivors was reviewed. Brain development and methodological issues that provide challenges to conducting meaningful research in cancer outcomes also are discussed.
RESULTS: Neurotoxic agents used in some cancer therapies produce permanent neurocognitive sequelae, especially in very young children.
CONCLUSIONS: The state of neurocognitive research for pediatric cancer survivors needs to move beyond empirical studies of neurocognitive sequelae to research that will identify individual patients at risk for neurocognitive morbidity.

Entities:  

Mesh:

Year:  2005        PMID: 15610985     DOI: 10.1093/jpepsy/jsi016

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  68 in total

1.  Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory ™ generic core scales, cancer module, and multidimensional fatigue scale in long-term adult survivors of pediatric cancer.

Authors:  Rhonda S Robert; Raheem J Paxton; Shana L Palla; Grace Yang; Martha A Askins; Shaini E Joy; Joann L Ater
Journal:  Pediatr Blood Cancer       Date:  2012-02-02       Impact factor: 3.167

2.  The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.

Authors:  Adrienne Viola; Lyn Balsamo; Joseph P Neglia; Pim Brouwers; Xiaomei Ma; Nina S Kadan-Lottick
Journal:  J Pediatr Hematol Oncol       Date:  2017-04       Impact factor: 1.289

3.  Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemia.

Authors:  Kevin R Krull; Raja B Khan; Kirsten K Ness; Davonna Ledet; Liang Zhu; Ching-Hon Pui; Scott C Howard; Deo Kumar Srivastava; Noah D Sabin; Melissa M Hudson; E Brannon Morris
Journal:  Pediatr Blood Cancer       Date:  2011-01-28       Impact factor: 3.167

Review 4.  Evidence-based assessment of cognitive functioning in pediatric psychology.

Authors:  Jonathan M Campbell; Ronald T Brown; Sarah E Cavanagh; Sarah F Vess; Mathew J Segall
Journal:  J Pediatr Psychol       Date:  2008-01-13

5.  Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study.

Authors:  M E Carey; M W Haut; S L Reminger; J J Hutter; R Theilmann; K L Kaemingk
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

6.  Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Heather M Conklin; Susan Helton; Jason Ashford; Raymond K Mulhern; Wilburn E Reddick; Ronald Brown; Melanie Bonner; Bruce W Jasper; Shengjie Wu; Xiaoping Xiong; Raja B Khan
Journal:  J Pediatr Psychol       Date:  2009-05-22

Review 7.  Mind-Body Therapies in Childhood Cancer.

Authors:  Germán Velez-Florez; María Camila Velez-Florez; Jose Oscar Mantilla-Rivas; Liliana Patarroyo-Rodríguez; Rodrigo Borrero-León; Santiago Rodríguez-León
Journal:  Curr Psychiatry Rep       Date:  2018-07-21       Impact factor: 5.285

Review 8.  Risk-based health monitoring of childhood cancer survivors: a report from the Children's Oncology Group.

Authors:  Susan B Nunez; Daniel A Mulrooney; Caroline Laverdiere; Melissa M Hudson
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

Review 9.  Preventing neurocognitive late effects in childhood cancer survivors.

Authors:  Martha A Askins; Bartlett D Moore
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

10.  The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validity.

Authors:  Kelly M Kenzik; I-Chan Huang; Tara M Brinkman; Brandon Baughman; Kirsten K Ness; Elizabeth A Shenkman; Melissa M Hudson; Leslie L Robison; Kevin R Krull
Journal:  Neuropsychology       Date:  2014-06-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.